Arix And China's Fosun Ink A Strategic Partnership
Executive Summary
A new strategic partnership has been forged between Arix Bioscience and China's Fosun International to develop new business opportunities in China.
You may also be interested in...
Evotec And Arix Bridge Gap With Latest Cancer Funding
Arix Biosciences and Evotec AG have formed an academic partnership to accelerate research discoveries at the Fred Hutchison Cancer Research Center.
Arix Says Latest Equity Raising May Be Last For Some Time As Exit Options Loom
Arix Bioscience's £87m equity raising brings to £250m the amount it has raised for incubating life sciences start-ups – but it might be the last for a while if portfolio 'exits' start generating cash, its CEO tells Scrip.
Arix Shepherds Atox $30m Funding Amid High Hopes For Start-up's Lead Asset
Its investment in Atox Bio's $30m Series F financing round added the 12th company to Arix's portfolio, hitting a target set at its February IPO. Atox’s late-stage peptide is designed to modulate a patient’s response to severe infections.